Skip to content
10-K

Annual Report

INTERPACE BIOSCIENCES, INC. IDXG

0001493152-26-013646

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 20, 2026 27.7M sh
Shares Diluted FY 2025 · Dec 31, 2025 27.7M sh
Shares Diluted FY 2025 · Dec 31, 2024 15.73M sh
Capex FY 2025 · Dec 31, 2025 $356K
Capex FY 2025 · Dec 31, 2024 $876K
Operating Cash Flow FY 2025 · Dec 31, 2025 $5.83M
Operating Cash Flow FY 2025 · Dec 31, 2024 $4.65M
Cash And Equivalents FY 2025 · Dec 31, 2025 $2.51M
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.46M
Stockholders Equity FY 2025 · Dec 31, 2025 $22.36M
Stockholders Equity FY 2025 · Dec 31, 2024 −$2.22M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$55.54M
Current Liabilities FY 2025 · Dec 31, 2025 $5.1M
Current Liabilities FY 2025 · Dec 31, 2024 $10.62M
Total Liabilities FY 2025 · Dec 31, 2025 $11.48M
Total Liabilities FY 2025 · Dec 31, 2024 $17.01M
Current Assets FY 2025 · Dec 31, 2025 $9.9M
Current Assets FY 2025 · Dec 31, 2024 $11.77M
Total Assets FY 2025 · Dec 31, 2025 $33.84M
Total Assets FY 2025 · Dec 31, 2024 $14.79M
Eps Diluted FY 2025 · Dec 31, 2025 $0.89
Eps Diluted FY 2025 · Dec 31, 2024 $0.40
Eps Basic FY 2025 · Dec 31, 2025 $5.55
Eps Basic FY 2025 · Dec 31, 2024 $1.42
Sga Expense FY 2025 · Dec 31, 2025 $9.48M
Sga Expense FY 2025 · Dec 31, 2024 $9.49M
Rd Expense FY 2025 · Dec 31, 2025 $642K
Rd Expense FY 2025 · Dec 31, 2024 $676K
Net Income FY 2025 · Dec 31, 2025 $24.58M
Net Income FY 2025 · Dec 31, 2024 $6.7M
Operating Income FY 2025 · Dec 31, 2025 $4.08M
Operating Income FY 2025 · Dec 31, 2024 $8.11M
Gross Profit FY 2025 · Dec 31, 2025 $24.13M
Gross Profit FY 2025 · Dec 31, 2024 $29.93M
Cost Of Revenue FY 2025 · Dec 31, 2025 $14.6M
Cost Of Revenue FY 2025 · Dec 31, 2024 $17M
Revenue FY 2025 · Dec 31, 2025 $38.73M
Revenue FY 2025 · Dec 31, 2024 $46.93M